Antidepressant medications and other treatments of depressive disorders:: a CINP Task Force report based on a review of evidence

被引：50

作者：

Baghai, Thomas C. ^{[1
]}

Baldwin, David S. ^{[3
]}

Barrett, Barbara ^{[4
]}

Baumann, Pierre ^{[9
]}

Ghalib, Kareem ^{[10
,11
]}

Goodwin, Guy ^{[6
]}

Grunze, Heinz ^{[1
,2
]}

Knapp, Martin ^{[4
]}

Leonard, Brian E. ^{[7
]}

Markowitz, John C. ^{[10
,11
]}

Padberg, Frank ^{[1
]}

Pinder, Roger ^{[8
]}

Sartorius, Norman

Brand, Ursula ^{[5
]}

Fink, Max ^{[12
]}

Furukawa, Toshiaki A. ^{[13
]}

Fountoulakis, Konstantinos N. ^{[14
]}

Jensen, Peter ^{[10
,11
]}

Kanba, Shigenobu

Riecher-Roessler, Anita ^{[15
]}

机构：

[1] Univ Munich, Dept Psychiat & Psychotherapy, D-80336 Munich, Germany

[2] Newcastle Univ, Royal Victoria Infirm, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England

[3] Royal S Hants Hosp, Univ Dept Psychiat, Southampton SO14 0YG, Hants, England

[4] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England

[5] European Federat Assoc Families Mentally III Peop, D-78462 Constance, Germany

[6] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OC3 7JX, England

[7] Natl Univ Ireland, Galway, Ireland

[8] Pharma Consultant, Shertogenbosch, Netherlands

[9] Univ Dept Psychiat, CH-1008 Prilly, Switzerland

[10] Columbia Univ, New York Presbyterian Hosp, New York, NY 10021 USA

[11] Cornell Univ, New York Presbyterian Hosp, New York, NY 10021 USA

[12] SUNY Stony Brook, Sch Med, Dept Psychiat, New York, NY USA

[13] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi 4678601, Japan

[14] Aristotle Univ Thessaloniki, Dept Psychiat 3, Thessaloniki, Greece

[15] Univ Basel Hosp, Psychiat Poliklin, CH-4031 Basel, Switzerland

来源：

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2007年 / 10卷

关键词：

D O I：

10.1017/S1461145707008255

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：S1 / S121

页数：121

共 161 条

[91]

Bambauer K.Z., Adams A.S., Zhang F., Minkoff N., Grande A., Weisblatt R., Soumerai S.B., Ross-Degnan D., Physician alerts to increase antidepressant adherence: Fax or fiction?, Arch. Intern. Med, 166, pp. 498-504, (2006)

[92]

Ban T.A., Pharmacotherapy of depression: A historical analysis, Journal of Neural Transmission, 108, pp. 707-716, (2001)

[93]

Ban T.A., Healy D., Shorter E., The rise of Psychopharmacology and The story on CINP, (1998)

[94]

Ban T.A., A history of the Collegium Internationale Neuro-Psychopharmacologicum (1957-2004), Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, pp. 599-616, (2006)

[95]

Ban T.A., Academic psychiatry and the pharmaceutical industry, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, pp. 429-441, (2006)

[96]

Bano S., Akhter S., Afridi M.I., Gender based response to fluoxetine hydrochloride medication in endogenous depression, Journal of the College of Physicians and Surgeons - Pakistan, 14, pp. 161-165, (2004)

[97]

Barbee J.G., Conrad E.J., Jamhour N.J., The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder, Journal of Clinical Psychiatry, 65, pp. 975-981, (2004)

[98]

Barbee J.G., Jamhour N.J., Lamotrigine as an augmentation agent in treatment-resistant depression, Journal of Clinical Psychiatry, 63, pp. 737-741, (2002)

[99]

Barbey J.T., Roose S.P., SSRI safety in overdose, Journal of Clinical Psychiatry, 59, SUPPL. 15, pp. 42-48, (1998)

[100]

Barbosa L., Berk M., Vorster M., A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes, Journal of Clinical Psychiatry, 64, pp. 403-407, (2003)

← 5 6 7 8 9 10 11 12 13 14 →